Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review

Introduction Haematological cancers are common in the UK, with a variety of morphologies. Stem cell transplants and chimeric antigen receptor (CAR) T-cell therapies provide significant options for hard to treat haematological cancers, although with difficult to predict outcomes. Research into the de...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishnarajah Nirantharakumar, Alastair K Denniston, Joht Singh Chandan, Nicola Adderley, David Burns, Samuel Cusworth, Zareen Deplano
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e099354.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849328541213130752
author Krishnarajah Nirantharakumar
Alastair K Denniston
Joht Singh Chandan
Nicola Adderley
David Burns
Samuel Cusworth
Zareen Deplano
author_facet Krishnarajah Nirantharakumar
Alastair K Denniston
Joht Singh Chandan
Nicola Adderley
David Burns
Samuel Cusworth
Zareen Deplano
author_sort Krishnarajah Nirantharakumar
collection DOAJ
description Introduction Haematological cancers are common in the UK, with a variety of morphologies. Stem cell transplants and chimeric antigen receptor (CAR) T-cell therapies provide significant options for hard to treat haematological cancers, although with difficult to predict outcomes. Research into the determinates of treatment efficacy, and access to treatments, is key to ensuring equal benefit across patients and patient safety. With this, there are concerns about the small representation of minority groups in related research. We aim to report on the current knowledge to guide future research.Methods and analysis A variety of databases will be searched for literature on UK minority ethnic populations receiving haematopoietic stem cell transplant or CAR T-cell therapy. Searches will be restricted to the year 2011 or later. Many outcomes will be analysed, covering the patient care pathway for those of the target population, although with a focus on follow-up after therapy. Plans have been made to conduct narrative synthesis, with meta-analysis where applicable.Ethics and dissemination Ethical approval is not required for this study. Outputs will be published in an appropriate journal and discussed with the wider National Institute for Health and Care Research Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics (BTRU) group. Discussions will also be undertaken with the BTRU patient partners group.
format Article
id doaj-art-d843ea73a7a74bd380817ffdb2f41b2d
institution Kabale University
issn 2044-6055
language English
publishDate 2025-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-d843ea73a7a74bd380817ffdb2f41b2d2025-08-20T03:47:33ZengBMJ Publishing GroupBMJ Open2044-60552025-05-0115510.1136/bmjopen-2025-099354Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic reviewKrishnarajah Nirantharakumar0Alastair K Denniston1Joht Singh Chandan2Nicola Adderley3David Burns4Samuel Cusworth5Zareen Deplano62 Department of Applied Health Sciences, University of Birmingham, Birmingham, UK4 Ophthalmology Department, Queen Elizabeth Hospital Birmingham, Birmingham, UK2 Department of Applied Health Sciences, University of Birmingham, Birmingham, UK2 Department of Applied Health Sciences, University of Birmingham, Birmingham, UK9 University Hospitals Plymouth NHS Trust, Plymouth, UK1 NIHR, Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, England, UK2 Department of Applied Health Sciences, University of Birmingham, Birmingham, UKIntroduction Haematological cancers are common in the UK, with a variety of morphologies. Stem cell transplants and chimeric antigen receptor (CAR) T-cell therapies provide significant options for hard to treat haematological cancers, although with difficult to predict outcomes. Research into the determinates of treatment efficacy, and access to treatments, is key to ensuring equal benefit across patients and patient safety. With this, there are concerns about the small representation of minority groups in related research. We aim to report on the current knowledge to guide future research.Methods and analysis A variety of databases will be searched for literature on UK minority ethnic populations receiving haematopoietic stem cell transplant or CAR T-cell therapy. Searches will be restricted to the year 2011 or later. Many outcomes will be analysed, covering the patient care pathway for those of the target population, although with a focus on follow-up after therapy. Plans have been made to conduct narrative synthesis, with meta-analysis where applicable.Ethics and dissemination Ethical approval is not required for this study. Outputs will be published in an appropriate journal and discussed with the wider National Institute for Health and Care Research Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics (BTRU) group. Discussions will also be undertaken with the BTRU patient partners group.https://bmjopen.bmj.com/content/15/5/e099354.full
spellingShingle Krishnarajah Nirantharakumar
Alastair K Denniston
Joht Singh Chandan
Nicola Adderley
David Burns
Samuel Cusworth
Zareen Deplano
Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
BMJ Open
title Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
title_full Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
title_fullStr Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
title_full_unstemmed Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
title_short Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular therapies, in the UK? A systematic review
title_sort protocol what are the ethnic inequities in care outcomes related to haematological malignancies treated with transplant cellular therapies in the uk a systematic review
url https://bmjopen.bmj.com/content/15/5/e099354.full
work_keys_str_mv AT krishnarajahnirantharakumar protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT alastairkdenniston protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT johtsinghchandan protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT nicolaadderley protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT davidburns protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT samuelcusworth protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview
AT zareendeplano protocolwhataretheethnicinequitiesincareoutcomesrelatedtohaematologicalmalignanciestreatedwithtransplantcellulartherapiesintheukasystematicreview